Sangamo Therapeutics(SGMO) - 2022 Q2 - Earnings Call Presentation

Sangam Pioneering the Future of Genomic Medicines August 2022 Forward-Looking Statements This presentation contains forward-looking statements regarding our current expectations. These forward-looking statements include, without limitation, statements relating to the potential to develop, obtain regulatory approvals for and commercialize durable, safe and effective therapies to treat certain diseases and the timing, availability and costs of such therapies, the potential to use ZFP, ZFP-TF, CAR-Treg and oth ...